In this study, we demonstrated that SERPINB2 was a tumor suppressor which inhibited metastasis and induced apoptosis (Figure 7), suggesting that it could be a novel therapeutic target for treating esophageal cancer. This evidence concerns the gene SERPINB2 and esophageal cancer.